Advanced search
Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 45, 2021 - Issue 2
Submit an article Journal homepage
66
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with β-Thalassemia Major

Danesh Soltania Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran;b Students’ Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, IranORCID Iconhttps://orcid.org/0000-0002-6253-9816
ORCID Icon,
Hossein Fakhrzadehc Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, IranCorrespondence[email protected],
,
Farshad Sharific Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
,
Mohammad Jafar Mahmoudid Department of Medicine, Amir-Alam Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
,
Elham Mahmoudid Department of Medicine, Amir-Alam Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
&
Ali Vasheghani-Farahania Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran
Pages 107-111 | Received 12 Feb 2021, Accepted 03 Mar 2021, Published online: 08 Apr 2021

References

  • Borgna Pignatti C, Cappellini MD, De Stefano P, et al. Survival and complications in thalassemia. Ann N Y Acad Sci. 2005;1054(1):40–47.
  • Borgna-Pignatti CA, Rugolotto SI, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004;89(10):1187–1193.
  • Wolfe L, Olivieri N, Sallan D, et al. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med. 1985;312(25):1600–1603.
  • Taksande A, Prabhu S, Venkatesh S. Cardiovascular aspect of beta-thalassaemia. Cardiovasc Hematol Agents Med Chem. 2012;10(1):25–30.
  • Wood JC. Cardiac complications in thalassemia major. Hemoglobin. 2009;33(sup1):S81–S86.
  • Aggeli C, Antoniades C, Cosma C, et al. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol. 2005;105(1):80–84.
  • Pattanapanyasat K, Gonwong S, Chaichompoo P, et al. Activated platelet derived microparticles in thalassaemia. Br J Haematol. 2007;136(3):462–471.
  • Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood. 2002;99(1):36–43.
  • Pratico D, Pasin M, Barry OP, et al. Iron-dependent human platelet activation and hydroxyl radical formation: involvement of protein kinase C. Circulation. 1999;99(24):3118–3124.
  • Schechter AN, Gladwin MT. Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med. 2003;348(15):1483–1485.
  • Mancini GBJ, Dahlöf B, Díez J. Surrogate markers for cardiovascular disease: structural markers. Circulation. 2004;109(25 Suppl 1):IV-22–IV-30.
  • Sherief LM, Dawood O, Ali A, et al. Premature atherosclerosis in children with beta-thalassemia major: new diagnostic marker. BMC Pediatr. 2017;17(1):69–77.
  • Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with β-thalassemia major. Circulation. 2002;106(20):2561–2566.
  • Hasimu B, Li J, Nakayama T, et al. Ankle brachial index as a marker of atherosclerosis in Chinese patients with high cardiovascular risk. Hypertens Res. 2006;29(1):23–28.
  • Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1):11.
  • Su TC, Chien KL, Jeng JS, et al. Age- and gender-associated determinants of carotid intima-media thickness: a community-based study. J Atheroscler Thromb. 2012;19(9):872–880.
  • Akhlaghpoor S, Hoseini M, Jafarisepehr A. Association of iron overload based quantitative T2* MRI technique and carotid intima-media thickness in patients with β-thalassemia: a cross-sectional study. BMC Cardiovasc Disord. 2010;10(1):62–880.
  • Tantawy AA, Adly AA, El Maaty MG, Amin SA. Subclinical atherosclerosis in young beta-thalassemia major patients. Hemoglobin. 2009;33(6):463–474.
  • Elkiran O, Yilmaz E, Koc M, et al. The association between intima media thickness, central obesity and diastolic blood pressure in obese and overweight children: a cross-sectional school-based study. Int J Cardiol. 2013;165(3):528–532.
  • Al-Domi H, Al-Shorman A. Increased waist circumference is associated with subclinical atherosclerosis in schoolchildren. Diabetes Metab Syndr. 2019;13(1):264–269.
  • Ge W, Parvez F, Wu F, et al. Association between anthropometric measures of obesity and subclinical atherosclerosis in Bangladesh. Atherosclerosis. 2014;232(1):234–241.
  • Gullu H, Caliskan M, Caliskan Z, et al. Coronary microvascular function, peripheral endothelial function and carotid IMT in beta-thalassemia minor. Thromb Res. 2013;131(6):e247–e252.
  • Kanda E, Ai M, Okazaki M, et al. Association of high-density lipoprotein subclasses with chronic kidney disease progression, atherosclerosis, and Klotho. PLoS One. 2016;11(11):e0166459
  • Lee IT, Huang CN, Lee WJ, et al. High total-to-HDL cholesterol ratio predicting deterioration of ankle brachial index in Asian type 2 diabetic subjects. Diabetes Res Clin Pract. 2008;79(3):419–426.
  • Hua S, Loehr LR, Tanaka H, et al. Ankle-brachial index and incident diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Cardiovasc Diabetol. 2016;15(1):163–171.
  • Duncan BB, Schmidt MI, Pankow JS, et al.; Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003;52(7):1799–1805.
  • Pinkney JH, Stehouwer CD, Coppack SW, et al. Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes. 1997;46(Suppl 2):S9–S13.
  • Meigs JB, Hu FB, Rifai N, et al. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004;291(16):1978–1986.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.